In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Insufficient knowledge of adults in Poland on criteria of arterial hypertension and its complications. Results of the NATPOL 2011 Survey

Session Poster Session III - Friday 08:30 - 12:30

Speaker Associate Professor Tomasz Zdrojewski

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Topic : hypertension
  • Sub-topic : Hypertension
  • Session type : Poster Session

Authors : K Suligowska (Gdansk,PL), M Gajewska (Warsaw,PL), J Stokwiszewski (Warsaw,PL), P Bandosz (Gdansk,PL), Z Gaciong (Warsaw,PL), B Wojtyniak (Warsaw,PL), M Rutkowski (Gdansk,PL), D Cianciara (Warsaw,PL), B Wyrzykowski (Gdansk,PL), T Zdrojewski (Gdansk,PL)

Authors:
K Suligowska1 , M Gajewska2 , J Stokwiszewski2 , P Bandosz1 , Z Gaciong3 , B Wojtyniak2 , M Rutkowski1 , D Cianciara2 , B Wyrzykowski4 , T Zdrojewski1 , 1Medical University of Gdansk, Department of Prevention and Education - Gdansk - Poland , 2National Institute of Cardiology, National Institute of Public Health - National Institute of Hygiene - Warsaw - Poland , 3Medical University of Warsaw, Department of Internal Medicine, Hypertension and Angiology - Warsaw - Poland , 4Medical University of Gdansk, Department of Hypertension and Diabetology - Gdansk - Poland ,

Citation:

Background Arterial hypertension is one of the most widespread cardiovascular disease risk factors. Among the
basic conditions of effective prevention, detection and treatment is appropriate knowledge in the general population about hypertension.
Material and methods The analysis was based on the results obtained in the research program NATPOL 2011. The survey covered a representative sample of adults in Poland: 2413 randomly selected subjects aged 18–79 years [1245 females (F) and 1168 males (M)]. Rated answers to the two open questions on upper limits of normal blood pressure and complications of untreated hypertension were assessed and calculated with regard to age, gender, education and place of residence. Statistical analysis was performed using multivariate logistic regression. To simplify the analysis of results, for upper limits of normal blood pressure were taken: 139–140 mm Hg and 89–90 mm Hg, for systolic and diastolic blood pressure, respectively
Results. Studies indicate that in Poland knowledge of blood pressure within normal limits is small. In terms of age (18-39 years; 40-59 years; 60-79 years) only 5.5%; 10.8%; 9.6% W and 5.9%; 7.8%; 6.1% M answered the questions correctly. Considering education (basic/essential; average; higher) percentage of W providing correct answers was 4.8%; 9.5%; 10.4%, and the percentage of M 3.4%; 9.4%: 8.4%. Furthermore, there was a very large discrepancy between the declared and actual knowledge of Poles, on the upper limits of normal blood pressure (for W: 79.4% vs. 8.4%; for M: 74.8% vs. 6.7%). Among all respondents in 2413 only 3 persons (0.1%) reported fully correct criteria HTN. Among the most frequently mentioned by respondents HTN complications were heart disease (69.8%), and stroke or cerebral ischemia (66%). In very little is known relationship between untreated HTN, and renal failure (11%) and blurred vision (7.7%). The study showed no significant differences in the knowledge W and M on the knowledge of the upper limits of normal blood pressure and complications of untreated HTN. Exceptions were: stroke (W: 72.1%; M: 59.6%), kidney damage (W: 14.4%; M: 7.4%) and blurred vision (W: 9.1%; M: 6.2%), where the women showed significantly better knowledge.
Conclusions. Knowledge of Poles about HTN criteria and complications that can be caused untreated HTN is insufficient. Therefore, it is necessary to conduct intensive educational activities in this field, and the results should provide guidance for the planning and implementation of these activities.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are